The FDA developed the precisionFDA database as part of the White House’s Precision Medicine Initiative. The hope is for the portal to use the DNA data in the database for next-generation sequencing, a process allowing scientists to obtain lengthy information on an individual’s genetic information.
“Ultimately, what we learn about these differences could be used to design a treatment tailored to a specific individual,” wrote Taha Kass-Hout, MD, and Elaine Johanson in a blog post announcing the launch. Dr. Kass-Hout is FDA’s chief health informatics officer and the director of the FDA’s Office of Health Informatics. Ms. Johanson is the project manager of precisionFDA.
Additionally, the code for the precisionFDA portal will be made public on GitHub, an open source software repository, allowing the community to enhance precisionFDA’s features.
To visit the precisionFDA web portal, click here.
More articles on genomics:
4 ways to protect patient privacy when sharing genome data
WEDI establishes genomic data exchange: 3 things to know
Boston company partners with Genomics England to sequence 100k genomes
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
